Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00693836
What this trial is testing

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Who this might be right for
Lung Cancer
Cancer Research Centre at Weston Park Hospital 2,000
Not applicableEnded earlyNCT00898209
What this trial is testing

Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 564
Large-scale testing (Phase 3)Study completedNCT00475098
What this trial is testing

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 553
Testing effectiveness (Phase 2)Study completedNCT00387465
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Looking for participantsNCT06693336
What this trial is testing

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
ToLymph Inc. 42
Testing effectiveness (Phase 2)WithdrawnNCT03628144
What this trial is testing

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNSCLCNon-small Cell Lung Cancer+4 more
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT02773238
What this trial is testing

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

Who this might be right for
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7
University of Washington 51
Early research (Phase 1)Study completedNCT02535325
What this trial is testing

Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Adenocarcinoma AJCC v7Stage III Lung Large Cell Carcinoma AJCC v7+10 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT03081689
What this trial is testing

Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 46
Testing effectiveness (Phase 2)Study completedNCT01068587
What this trial is testing

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 31
Testing effectiveness (Phase 2)Study completedNCT03916419
What this trial is testing

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

Who this might be right for
Stage IIB Non-Small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
Washington University School of Medicine 26
Not applicableActive Not RecruitingNCT04430725
What this trial is testing

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study

Who this might be right for
Lung Non-Small Cell CarcinomaMetastatic Colorectal CarcinomaMetastatic Sarcoma+19 more
M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Study completedNCT00278148
What this trial is testing

Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Nathan Pennell, MD, PhD 32
Large-scale testing (Phase 3)Active Not RecruitingNCT03425643
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 797
Early research (Phase 1)Ended earlyNCT00049608
What this trial is testing

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
National Center for Complementary and Integrative Health (NCCIH) 51
Testing effectiveness (Phase 2)Ended earlyNCT00281827
What this trial is testing

Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00014430
What this trial is testing

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT00103116
What this trial is testing

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Edward Hirschowitz 32
Testing effectiveness (Phase 2)Study completedNCT00301808
What this trial is testing

Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 29
Next Page